Skip to content
Methodology
All entries for: AbbVie Inc.
July 27, 2025
AbbVie Inc.
Orphan Drug Designation
FDA orphan drug designation: treatment of gastric and gastro-esophageal junction cancer
Disease Area:
Rare Diseases
Source
Scroll to Top